
Mohammed Hasan Nemat Al-Musawi MD ,MBChB,MSc,FRCS (He/Him)
Physician
Join to View Full Profile
13001 E 17th PlAurora, CO 80045
Phone+1 303-724-9251
Dr. Al-Musawi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Baghdad College of MedicineClass of 1994
Clinical Trials
- Implementation of Vascular Care Team to Improve Medical Management of PAD Patients Start of enrollment: 2020 Jul 07
Roles: Contact
- Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization Start of enrollment: 2019 Oct 01
Roles: Contact
Publications & Presentations
PubMed
- Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer Database.Toshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, Michael J Kirsch, Kathryn Colborn
Pancreatology. 2024-12-01 - 8 citationsPathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy.Thomas F Stoop, Atsushi Oba, Y H Andrew Wu, Laurel E Beaty, Kathryn L Colborn
JAMA Network Open. 2024-06-03 - 12 citationsNeoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study.Toshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, Robert J Torphy, Kathryn Colborn
Annals of Surgery. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: